[The internal medicine articles that struck us the most in 2019]

Yoris Demars1, Oriane Aebischer1, Yana Apostolova1

  • 1Service de médecine interne, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|January 23, 2020
PubMed

Insights

This review highlights key 2019 internal medicine advancements, including new uses for SGLT2 inhibitors and rivaroxaban, optimal antibiotic durations, and timing for cardiac interventions like cardioversion and sacubitril/valsartan initiation.

Area of Science:

  • Internal Medicine
  • Clinical Practice Updates

Background:

  • 2019 saw significant advancements across internal medicine disciplines.
  • Keeping abreast of novel findings impacts daily clinical practice.

Purpose of the Study:

  • To present a curated selection of eleven impactful articles from 2019.
  • To summarize and comment on recent internal medicine literature for practitioners.

Main Methods:

  • Review of key internal medicine journals from 2019.
  • Selection, summarization, and commentary by chief residents.
  • Focus on practical implications for daily medical practice.

Main Results:

  • New indications for SGLT2 inhibitors and rivaroxaban.
  • Guidance on antibiotic duration for Gram-negative bacteremia.
  • Evidence-based recommendations on timing for cardioversion and sacubitril/valsartan therapy.

Conclusions:

  • The selected articles represent crucial updates for internal medicine specialists.
  • These summaries provide accessible insights into recent clinical practice advancements.

Related Concept Videos